solute carrier family 35 member A2
Ultimo aggiornamento 18 Ago 2020
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
L SLC35A2 gene provides instructions for making an enzyme called UDP-galactose translocator (UGT). This enzyme is involved in a process called glycosylation. During this process, complex chains of sugar molecules (oligosaccharides) are added to proteins and fats (lipids). Glycosylation modifies proteins and lipids so they can fully perform their functions. The UGT enzyme transfers a simple sugar called galactose to growing oligosaccharides at a particular step in the formation of the sugar chain. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or lipid.
Scelte video per GenesVideo library
Normal function
L SLC35A2 gene provides instructions for making an enzyme called UDP-galactose translocator (UGT). This enzyme is involved in a process called glycosylation. During this process, complex chains of sugar molecules (oligosaccharides) are added to proteins and fats (lipids). Glycosylation modifies proteins and lipids so they can fully perform their functions. The UGT enzyme transfers a simple sugar called galactose to growing oligosaccharides at a particular step in the formation of the sugar chain. Once the correct number of sugar molecules are linked together, the oligosaccharide is attached to a protein or lipid.
Two versions of the enzyme, known as UGT1 and UGT2, are produced from the SLC35A2 gene. These enzymes differ in only a few protein building blocks (amino acids) and can function together or separately in different areas of the cell.
Conditions referring to this gene or chromosome
Altri nomi
solute carrier family 35 (UDP-galactose transporter), member 2
solute carrier family 35 (UDP-galactose transporter), member A2
UDP-Gal-Tr
UDP-galactose translocator
UGALT
UGAT
UGT
UGT1
UGT2
UGTL
Related patient information and medicines

Patient information leaflet
Fibrosi cistica
Che cos'è cystic fibrosis. Cystic fibrosis is a condition which mainly affects the lungs and pancreas but can affect other parts of the body, including the liver, nose and sinuses and sweat glands. Normally, cells in these parts of the body make mucus an... What causes cystic fibrosis. Cystic fibrosis is a genetic disorder. A genetic disorder is one.

Patient information leaflet
Pianificare una gravidanza
The aim is to plan ahead to reduce the risk of any harm to the baby and to reduce the risk of la gravidanza complications. Women on regular medication, or who have a long-term medical condition, may need to seek medical advice to discuss any changes which may need to be made. There is a summary checklist at the end of the leaflet. However women who.

Patient information leaflet
Malattia renale policistica
The two common problems that develop are high blood pressure High blood pressure and chronic kidney disease (CKD) Cronica kidney disease. About half of ADPKD cases lead to kidney failure requiring dialysis or a kidney transplant. What is polycystic kidney disease. A cyst is a fluid-filled sac. Cysts occur in various sizes, in various conditions.

Patient information leaflet
Disordini di accumulo di glicogeno
Disordini di accumulo di glicogeno sono a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Newer treatment possibilities.

Patient information leaflet
Glaucoma
By the age of 70, about 1 in 33 people in the UK have glaucoma. Glaucoma is unusual in people under the age of 35. Glaucoma può affect anyone but it is more common se you: Avere a family history of glaucoma (if a parent, brother or sister has glaucoma, you are 2-4 times more likely than other people to develop it yourself). Have very short sight..

Patient information leaflet
Alcohol use disorder
Some people can find it very difficult to control, or stop, their drinking. What is alcohol use disorder. Alcohol use disorder means drinking alcohol in a way that causes harm. If you or a family member has alcohol use disorder then treatment and support can be provided to help you or your family member reduce or stop drinking alcohol. Alcohol use.
Ulteriori letture e riferimenti
- solute carrier family 35 member A2; MedlinePlus, National Library of Medicine.
- Dorre K, Olczak M, Wada Y, Sosicka P, Gruneberg M, Reunert J, Kurlemann G, Fiedler B, Biskup S, Hortnagel K, Rust S, Marquardt T. A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach. J Inherit Metab Dis. 2015 Sep;38(5):931-40. doi: 10.1007/s10545-015-9828-6. Epub 2015 Mar 17.
- Kimizu T, Takahashi Y, Oboshi T, Horino A, Koike T, Yoshitomi S, Mori T, Yamaguchi T, Ikeda H, Okamoto N, Nakashima M, Saitsu H, Kato M, Matsumoto N, Imai K. A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy. Brain Dev. 2017 Mar;39(3):256-260. doi: 10.1016/j.braindev.2016.09.009. Epub 2016 Oct 12.
- Kodera H, Nakamura K, Osaka H, Maegaki Y, Haginoya K, Mizumoto S, Kato M, Okamoto N, Iai M, Kondo Y, Nishiyama K, Tsurusaki Y, Nakashima M, Miyake N, Hayasaka K, Sugahara K, Yuasa I, Wada Y, Matsumoto N, Saitsu H. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat. 2013 Dec;34(12):1708-14. doi: 10.1002/humu.22446. Epub 2013 Oct 15.
- Ng BG, Buckingham KJ, Raymond K, Kircher M, Turner EH, He M, Smith JD, Eroshkin A, Szybowska M, Losfeld ME, Chong JX, Kozenko M, Li C, Patterson MC, Gilbert RD, Nickerson DA, Shendure J, Bamshad MJ; University of Washington Center for Mendelian Genomics; Freeze HH. Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet. 2013 Apr 4;92(4):632-6. doi: 10.1016/j.ajhg.2013.03.012.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

